13 yrs old boy with dengue igM positive Explain about dengue symptoms mechanism monitoring in hospital

Reading File
Finding Sources
Finding Sources
Searching Images

dengue fever pathophysiology rash clinical features

Clinical photograph of a male patient's torso and upper extremities in a hospital setting, illustrating a diffuse, patchy erythematous rash. The skin lesions are most prominent across the upper chest, mid-abdomen, and bilateral arms, with red arrows highlighting the erythematous distribution on the right pectoral region and left forearm. The morphology is consistent with a dissipating maculopapular or morbilliform eruption often seen in systemic viral infections such as Dengue fever. Notable clinical features include the absence of visible scaling and a generalized, non-confluent pattern. On the patient's left forearm, an indwelling intravenous (IV) catheter is secured with a transparent adhesive dressing and tape, and a white hospital identification band is visible on the wrist. This visual evidence supports the clinical assessment of infectious exanthems in the context of systemic illness and thrombocytopenia.

Clinical photograph of a male patient's torso and upper extremities in a hospital setting, illustrating a diffuse, patchy erythematous rash. The skin lesions are most prominent across the upper chest, mid-abdomen, and bilateral arms, with red arrows highlighting the erythematous distribution on the right pectoral region and left forearm. The morphology is consistent with a dissipating maculopapular or morbilliform eruption often seen in systemic viral infections such as Dengue fever. Notable clinical features include the absence of visible scaling and a generalized, non-confluent pattern. On the patient's left forearm, an indwelling intravenous (IV) catheter is secured with a transparent adhesive dressing and tape, and a white hospital identification band is visible on the wrist. This visual evidence supports the clinical assessment of infectious exanthems in the context of systemic illness and thrombocytopenia.

Clinical photograph series showing skin manifestations of dengue fever in a 25-year-old male. Panels A and B display the anterior (chest/abdomen) and posterior (back) trunk, revealing a generalized, pruritic eruption. The rash is characterized by erythematous wheals that are partially confluent, creating a map-like or mottled appearance with areas of normal skin interspersed. Panels C and D show similar lesions on the upper extremities, demonstrating raised, irregularly shaped, pink-to-red wheals across the forearms and wrists. A singular ecchymosis (bruise) is visible on the distal forearm in panel D. The morphology is consistent with urticarial-like lesions frequently observed in the early stages of viral exanthems. The images serve as an educational reference for recognizing atypical dermatological presentations of dengue virus infection, distinguishing them from classic petechial rashes.

Clinical photograph series showing skin manifestations of dengue fever in a 25-year-old male. Panels A and B display the anterior (chest/abdomen) and posterior (back) trunk, revealing a generalized, pruritic eruption. The rash is characterized by erythematous wheals that are partially confluent, creating a map-like or mottled appearance with areas of normal skin interspersed. Panels C and D show similar lesions on the upper extremities, demonstrating raised, irregularly shaped, pink-to-red wheals across the forearms and wrists. A singular ecchymosis (bruise) is visible on the distal forearm in panel D. The morphology is consistent with urticarial-like lesions frequently observed in the early stages of viral exanthems. The images serve as an educational reference for recognizing atypical dermatological presentations of dengue virus infection, distinguishing them from classic petechial rashes.

This clinical photograph displays a diffuse exanthematous rash on a patient's torso, characteristic of the later stages of Dengue Fever. The image reveals generalized, confluent erythema that covers a broad anatomical area. A hallmark diagnostic feature is visible: the presence of multiple, small, rounded 'islands of sparing'—pale, unaffected areas of skin that stand out against the erythematous background, often referred to as 'white islands in a sea of red.' Additionally, there is evidence of dermatographism or linear erythematous streaks, likely resulting from pressure or scratching. This cutaneous manifestation typically appears 3–6 days after the onset of fever and represents a key clinical sign for differentiating Dengue Fever from other tropical febrile illnesses. The rash serves as an important educational example of viral exanthems and their unique morphological patterns in infectious disease and dermatology.

This clinical photograph displays a diffuse exanthematous rash on a patient's torso, characteristic of the later stages of Dengue Fever. The image reveals generalized, confluent erythema that covers a broad anatomical area. A hallmark diagnostic feature is visible: the presence of multiple, small, rounded 'islands of sparing'—pale, unaffected areas of skin that stand out against the erythematous background, often referred to as 'white islands in a sea of red.' Additionally, there is evidence of dermatographism or linear erythematous streaks, likely resulting from pressure or scratching. This cutaneous manifestation typically appears 3–6 days after the onset of fever and represents a key clinical sign for differentiating Dengue Fever from other tropical febrile illnesses. The rash serves as an important educational example of viral exanthems and their unique morphological patterns in infectious disease and dermatology.

This composite of clinical photographs illustrates the classic dermatological and ocular manifestations of Dengue fever. Panel (a) displays a characteristic confluent erythematous, blanching maculopapular rash on the chest, often described as 'islands of white in a sea of red' due to distinct patches of skin sparing. Additionally, circular ecchymotic lesions are visible on the lateral chest wall, corresponding to pressure sites from ECG electrodes. An inset focuses on the patient's face, showing bilateral subconjunctival hemorrhages and periorbital ecchymoses. Panel (b) illustrates peripheral vascular involvement, showing cutaneous vasculitis of the fingers and toes, characterized by intense erythema and swelling. The lower panel in (b) further demonstrates the diffuse erythematous rash on the lower limb with smaller focal spots of skin sparing. These findings are hallmarks of Dengue Hemorrhagic Fever (DHF) and emphasize the systemic vascular permeability and coagulopathy associated with the virus.

This composite of clinical photographs illustrates the classic dermatological and ocular manifestations of Dengue fever. Panel (a) displays a characteristic confluent erythematous, blanching maculopapular rash on the chest, often described as 'islands of white in a sea of red' due to distinct patches of skin sparing. Additionally, circular ecchymotic lesions are visible on the lateral chest wall, corresponding to pressure sites from ECG electrodes. An inset focuses on the patient's face, showing bilateral subconjunctival hemorrhages and periorbital ecchymoses. Panel (b) illustrates peripheral vascular involvement, showing cutaneous vasculitis of the fingers and toes, characterized by intense erythema and swelling. The lower panel in (b) further demonstrates the diffuse erythematous rash on the lower limb with smaller focal spots of skin sparing. These findings are hallmarks of Dengue Hemorrhagic Fever (DHF) and emphasize the systemic vascular permeability and coagulopathy associated with the virus.

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Searching Images

dengue warning signs hemorrhagic fever shock syndrome platelet

Clinical photograph of a patient's arm demonstrating bleeding manifestations characteristic of Dengue Shock Syndrome (DSS). The image is divided into two panels: (a) shows the full arm in a clinical setting with an intravenous (IV) line secured to the hand, and (b) provides a close-up view of the upper arm. Both panels highlight linear petechiae (indicated by black arrows), which are small, red to purplish hemorrhagic spots arranged in distinct linear patterns. These lesions represent microvascular fragility and are shown following the inflation of a blood pressure cuff (Hess test or capillary fragility test), a common diagnostic maneuver for assessing vascular permeability in dengue fever. The presence of an IV line and hospital bedding contextualizes the severity of the illness, illustrating the systemic plasma leakage and hemostatic dysfunction associated with severe viral hemorrhagic fevers. Key educational concepts include endothelial dysfunction, capillary fragility, and clinical signs of thrombocytopenia or vasculopathy.

Clinical photograph of a patient's arm demonstrating bleeding manifestations characteristic of Dengue Shock Syndrome (DSS). The image is divided into two panels: (a) shows the full arm in a clinical setting with an intravenous (IV) line secured to the hand, and (b) provides a close-up view of the upper arm. Both panels highlight linear petechiae (indicated by black arrows), which are small, red to purplish hemorrhagic spots arranged in distinct linear patterns. These lesions represent microvascular fragility and are shown following the inflation of a blood pressure cuff (Hess test or capillary fragility test), a common diagnostic maneuver for assessing vascular permeability in dengue fever. The presence of an IV line and hospital bedding contextualizes the severity of the illness, illustrating the systemic plasma leakage and hemostatic dysfunction associated with severe viral hemorrhagic fevers. Key educational concepts include endothelial dysfunction, capillary fragility, and clinical signs of thrombocytopenia or vasculopathy.

This diagnostic image is an anteroposterior (AP) chest X-ray demonstrating severe pulmonary edema and pleural effusion in a 19-year-old female patient with Dengue Shock Syndrome. The lung fields show bilateral, diffuse, fluffy opacities and increased interstitial markings, characteristic of pulmonary edema. There is significant blunting of the right costophrenic angle, indicating a right-sided pleural effusion. The cardiac silhouette appears moderately enlarged, and the normal clear visualization of pulmonary vasculature is obscured by interstitial and alveolar infiltrates. ECG electrodes and leads are visible on the chest wall, reflecting an acute clinical monitoring setting. This imaging serves as a critical educational example of 'third space' fluid accumulation and capillary leak syndrome secondary to viral hemorrhagic fever, illustrating the rapid progression of respiratory distress during fluid resuscitation in Dengue Shock Syndrome.

This diagnostic image is an anteroposterior (AP) chest X-ray demonstrating severe pulmonary edema and pleural effusion in a 19-year-old female patient with Dengue Shock Syndrome. The lung fields show bilateral, diffuse, fluffy opacities and increased interstitial markings, characteristic of pulmonary edema. There is significant blunting of the right costophrenic angle, indicating a right-sided pleural effusion. The cardiac silhouette appears moderately enlarged, and the normal clear visualization of pulmonary vasculature is obscured by interstitial and alveolar infiltrates. ECG electrodes and leads are visible on the chest wall, reflecting an acute clinical monitoring setting. This imaging serves as a critical educational example of 'third space' fluid accumulation and capillary leak syndrome secondary to viral hemorrhagic fever, illustrating the rapid progression of respiratory distress during fluid resuscitation in Dengue Shock Syndrome.

This clinical photograph shows the bilateral lower extremities of a 47-year-old male presenting with a diffuse dermatologic manifestation of thrombocytopenia. The skin demonstrates widespread, non-blanching petechiae, appearing as numerous pinpoint-sized (1-2 mm), reddish-purple macules. These lesions are densely scattered across the anterior and lateral aspects of the shins and calves. In addition to the petechial rash, several larger, coalescent purpuric lesions and subtle ecchymoses are visible, indicating small-vessel bleeding into the dermis. The background skin exhibits generalized erythema. This visual finding is characteristic of severe thrombocytopenia, in this clinical context associated with a viral hemorrhagic fever such as dengue. The image serves as an educational example of the cutaneous signs of low platelet counts and the systemic progression of infectious diseases like dengue fever in a hospital setting.

This clinical photograph shows the bilateral lower extremities of a 47-year-old male presenting with a diffuse dermatologic manifestation of thrombocytopenia. The skin demonstrates widespread, non-blanching petechiae, appearing as numerous pinpoint-sized (1-2 mm), reddish-purple macules. These lesions are densely scattered across the anterior and lateral aspects of the shins and calves. In addition to the petechial rash, several larger, coalescent purpuric lesions and subtle ecchymoses are visible, indicating small-vessel bleeding into the dermis. The background skin exhibits generalized erythema. This visual finding is characteristic of severe thrombocytopenia, in this clinical context associated with a viral hemorrhagic fever such as dengue. The image serves as an educational example of the cutaneous signs of low platelet counts and the systemic progression of infectious diseases like dengue fever in a hospital setting.

I now have comprehensive textbook content. Let me compile the full answer.

Dengue in a 13-Year-Old Boy (IgM Positive)

This is a confirmed dengue case in a pediatric patient. Here is a complete breakdown of the disease - symptoms, mechanism, and hospital monitoring.

1. The Virus - Background

Dengue is caused by four RNA flaviviruses (DENV 1-4), transmitted by the bite of Aedes aegypti (and less commonly Aedes albopictus) mosquitoes. The incubation period is 4-7 days. About 75% of infections are asymptomatic; only ~25% are symptomatic. Globally, 400 million people are infected each year.
  • Red Book 2021, p. 520
  • Sherris & Ryan's Medical Microbiology, p. 646

2. Mechanism / Pathophysiology

Viral Entry and Replication

The virus infects monocytes, macrophages, and dendritic cells. It replicates inside cells and triggers a massive immune response (TNF-α, IL-6, IL-8, interferon release), causing endothelial dysfunction.

Antibody-Dependent Enhancement (ADE) - Key Mechanism for Severe Disease

  • First infection with one serotype produces lifelong immunity against that serotype only
  • Cross-reactive antibodies from the first infection are non-neutralizing against other serotypes
  • On second infection with a different serotype, these cross-reactive antibodies actually enhance viral entry into macrophages via Fc receptors - this is ADE
  • ADE dramatically increases viral load and triggers a cytokine storm, leading to severe dengue (DHF/DSS)
  • This is why severe dengue is more common in children in endemic areas (who may have had prior infection) and in infants born to dengue-immune mothers

Plasma Leakage - The Critical Pathology

The cytokine storm causes increased vascular permeability - plasma leaks out of blood vessels into third spaces (pleural cavity, peritoneum). This leads to:
  • Rising hematocrit (hemoconcentration)
  • Hypovolemic shock
  • Pleural effusion, ascites

Thrombocytopenia Mechanism

  • Virus directly infects megakaryocytes (platelet precursors), reducing platelet production
  • Cross-reactive antibodies against platelets cause immune-mediated platelet destruction
  • Endothelial activation consumes platelets
  • Result: platelet count can drop below 20,000/µL
  • Robbins Pathologic Basis of Disease, p. 336-337

3. Clinical Symptoms - Three Phases

Phase 1: Febrile Phase (Days 1-3)

SymptomNotes
Sudden high fever (39-40°C)Abrupt onset, lasts 2-7 days
Severe headacheFrontal/retro-orbital (behind eyes) - classic
Myalgia / arthralgia"Breakbone fever" - intense bone and joint pain
Facial erythema, flushing
Nausea / vomiting
Maculopapular rashAppears days 2-5
Mild bleedingPetechiae, nosebleed, gum bleed
LeukopeniaWBC typically falls

Phase 2: Critical Phase (Days 3-7, around defervescence)

This is the most dangerous period - when fever subsides, plasma leakage peaks. The child may appear to improve but is actually at highest risk.
Warning Signs of Severe Dengue (WHO 2009 - require urgent admission):
  • Abdominal pain or tenderness
  • Persistent vomiting (3+ episodes in 1 hour)
  • Clinical fluid accumulation (pleural effusion, ascites)
  • Mucosal bleeding
  • Lethargy, restlessness, behavioral change
  • Liver enlargement >2 cm
  • Rapid decline in platelet count with rising hematocrit

Phase 3: Convalescence (Days 7-10)

  • Gradual improvement, fluid reabsorption
  • Secondary rash may appear - "white islands in a sea of red" (areas of sparing amid erythema)
  • Fatigue and bradycardia common
  • Risk of fluid overload as third-space fluid is reabsorbed
  • Red Book 2021, p. 520-521

4. Dengue Severity Classification (WHO 2009)

CategoryCriteria
Dengue without warning signsFever + 2 of: nausea/vomiting, rash, aches, leukopenia, positive tourniquet test
Dengue with warning signsAbove + any warning sign (see Phase 2 above)
Severe dengueSevere plasma leakage (shock/respiratory distress), severe bleeding, or severe organ involvement (AST/ALT ≥1000 IU/L, impaired consciousness, organ failure)

5. Clinical Images

Typical dengue rash - "white islands in a sea of red":
Dengue rash - white islands in sea of red
Urticarial/maculopapular dengue rash on trunk and arms:
Dengue urticarial rash on trunk and arms
Petechiae from positive tourniquet test / thrombocytopenia:
Petechiae and linear bleeding in dengue shock syndrome
Chest X-ray in Dengue Shock Syndrome - bilateral pleural effusion and pulmonary edema:
Chest X-ray showing pleural effusion in dengue shock syndrome

6. Hospital Monitoring Protocol

Daily Monitoring (Minimum)

ParameterFrequencyWhy
TemperatureEvery 4-6 hoursTrack febrile and defervescence phase
Pulse rate & BPEvery 4-6 hours (hourly if warning signs)Detect early shock
Respiratory rateEvery 4-6 hoursDetect pleural effusion
Urine outputEvery 6-8 hoursTarget >0.5 mL/kg/hr; drop indicates shock
Capillary refill timeEvery 4-6 hoursPeripheral perfusion

Laboratory Monitoring

TestFrequencyTarget / Action
CBC with plateletsEvery 12-24 hours (daily); every 6-8 hrs if <50,000Platelets <20,000 or rapid fall = danger; Hematocrit rise >20% above baseline = plasma leakage
Hematocrit (PCV)Every 6-12 hours in critical phaseRising Hct = plasma leak; falling Hct = dilution from reabsorption or occult bleeding
Liver function (AST/ALT)Every 24-48 hoursAST/ALT ≥1000 = severe dengue criterion
Serum electrolytesDailyHyponatremia common
Blood urea / creatinineEvery 24-48 hoursRenal impairment in shock
Coagulation (PT/aPTT)If bleeding occursDIC screen
Blood glucoseAs neededHypoglycemia in hepatitis

Clinical Monitoring at Bedside

  • Tourniquet test (positive = ≥20 petechiae in 1-inch square): assess capillary fragility on admission
  • Check for abdominal tenderness and measure liver span daily
  • Auscultate chest for pleural effusion (reduced air entry at bases)
  • Monitor for abdominal distension (ascites)
  • Watch for mucosal bleeding (gums, nose), melena, hematemesis

Fluid Management Monitoring

  • Avoid aspirin and NSAIDs (increase bleeding risk) - use paracetamol only for fever
  • During febrile phase: encourage oral hydration; IV fluids if unable to tolerate orally
  • During critical phase: IV crystalloids (Ringer's lactate / normal saline), titrate to clinical response
  • Monitor for fluid overload during convalescence (reabsorption phase) - watch for new respiratory distress, rising pulse, falling Hct
  • Refractory shock: may need colloids or blood products

Indications for ICU / Escalation

  • Systolic BP <90 mmHg or pulse pressure ≤20 mmHg
  • Platelet <20,000/µL with active bleeding
  • Hematocrit rise >20% from baseline
  • Impaired consciousness
  • Respiratory distress / SpO2 <95%
  • Persistent vomiting preventing oral hydration

7. Investigations Summary for This 13-Year-Old

InvestigationStatus/Purpose
Dengue IgMAlready positive - confirms infection from day 3-5
Dengue NS1 antigenUseful in first 7 days (may be negative now if late)
Dengue IgGIf positive alongside IgM = secondary infection (higher risk of severe dengue)
RT-PCRMost specific; detectable days 1-7 only
CBC dailyEssential monitoring
LFTBaseline and daily if unwell
Chest X-ray / USG abdomenIf respiratory symptoms or abdominal pain (detect effusion, ascites)

8. Treatment Summary

There is no specific antiviral therapy for dengue. Management is entirely supportive:
  1. Paracetamol for fever (avoid aspirin, ibuprofen, diclofenac)
  2. Oral hydration aggressively during febrile phase
  3. IV fluids (crystalloids) during critical phase if clinically deteriorating
  4. Blood transfusion / platelets only for significant bleeding or very low platelets with clinical instability (not prophylactically)
  5. Close monitoring as described above - early recognition of shock saves lives
Early recognition of shock and intensive supportive therapy reduces mortality from severe dengue from ~5-10% down to less than 1%. - Red Book 2021, p. 522

Key Points for This Child

  • 13 years old - at age where secondary infection is plausible if in endemic area; higher risk of severe dengue
  • IgM positive confirms active infection; check if IgG is also positive (secondary infection = higher risk)
  • The critical phase (days 3-7) is when the child needs the closest monitoring even if fever seems to be resolving
  • Discharge only after: fever-free for 24-48 hours, platelet count rising (>50,000), no warning signs, adequate oral intake, stable hematocrit
Sources: Red Book 2021 - Report of the Committee on Infectious Diseases, pp. 520-524 | Robbins Pathologic Basis of Disease, pp. 335-337 | Sherris & Ryan's Medical Microbiology, pp. 646-647 | Harrison's Principles of Internal Medicine 22E
This is a shared conversation. Sign in to Orris to start your own chat.